Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

NCT00593255 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DRUG: soluble human insulin
DRUG: insulin aspart
DRUG: insulin NPH

Sponsor

Novo Nordisk A/S